Search Results

Diane Coleman, 71, Advocate for Disability Rights.

• Authors : RISEN, CLAY

Subjects: DISABILITIES; MUSCULAR atrophy; MOTOR neurons

• Source: New York Times. 11/21/2024, Vol. 174 Issue 60345, pB11-B11. 1/3p.

Record details

Motor neurons derived from patients point to new possible drug target for ALS

• Authors : PR Newswire

Subjects: Massachusetts

• Source: PR Newswire US. 06/08/2021.

Record details

Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study

• Authors : PR Newswire

Subjects: Australia; New York

• Source: PR Newswire US. 11/19/2024.

Record details

Mitsubishi Tanabe Pharma America to Showcase ALS Research at 2024 AANEM Annual Meeting

• Authors : PR Newswire

Subjects: New Jersey

• Source: PR Newswire US. 10/15/2024.

Record details

Revalesio's Investigational Treatment RNS60 Protects Mitochondria in Preclinical Model of Amyotrophic Lateral Sclerosis (ALS)

• Authors : PR Newswire

Subjects: Washington

• Source: PR Newswire US. 10/09/2024.

Record details

This week in science: a sea creature, healing the nervous system and holiday eating.

• Authors : Emily Kwong; Regina Barber; Ari Shapiro ...

• Source: All Things Considered (NPR). 11/14/2024.

Record details

Prostate drug could treat motor neurone disease

• Authors : Lauren Gilmour

• Source: Times, The (United Kingdom). 08/11/2022, p16-16. 1.

Record details

"Stem Cell Therapy Perspectives in Treating Motor Neuron Diseases: ALS and SMA" by BioPolaris April 2010

• Source: M2PressWIRE. 04/15/2010.

Record details

Amyotrophic Lateral Sclerosis (ALS) Markets - $1.04 Billion Opportunity Analysis and Forecasts to 2029: Biogen, Mitsubishi, and BrainStorm are Forecast to Lead the ALS Market

• Source: M2PressWIRE. 10/01/2020.

Record details

Boosts for ALS research: A $15-million grant to Columbia and a new private lab are both aimed at roots of the degenerative disease

• Authors : Talan, Jamie

• Source: Newsday, (Melville, NY). 05/30/2006.

Record details